Q3 2024 Earnings Estimate for Aclaris Therapeutics, Inc. Issued By HC Wainwright (NASDAQ:ACRS)
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – Investment analysts at HC Wainwright boosted their Q3 2024 EPS estimates for shares of Aclaris Therapeutics in a research note issued on Monday, July 22nd. HC Wainwright analyst R. Selvaraju now forecasts that the biotechnology company will earn ($0.14) per share for the quarter, up from their […]
More Stories
Stratos Wealth Partners LTD. Buys 210 Shares of Lockheed Martin Co. (NYSE:LMT)
Stratos Wealth Partners LTD. boosted its position in Lockheed Martin Co. (NYSE:LMT – Free Report) by 2.0% during the third...
Accurate Wealth Management LLC Decreases Stock Holdings in Accenture plc (NYSE:ACN)
Accurate Wealth Management LLC lessened its position in Accenture plc (NYSE:ACN – Free Report) by 9.3% during the third quarter,...
Moss Adams Wealth Advisors LLC Acquires New Stake in Boston Scientific Co. (NYSE:BSX)
Moss Adams Wealth Advisors LLC bought a new position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) in...
Moss Adams Wealth Advisors LLC Invests $234,000 in Marsh & McLennan Companies, Inc. (NYSE:MMC)
Moss Adams Wealth Advisors LLC acquired a new stake in Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report) in...
Goldfinch Tops 1-Day Trading Volume of $886,917.43 (GFI)
Goldfinch (GFI) traded down 1.5% against the dollar during the 24-hour period ending at 8:00 AM ET on October 20th....
ANDY (ANDY) Reaches 1-Day Volume of $1.45 Million
ANDY (ANDY) traded 7.9% lower against the dollar during the 1-day period ending at 8:00 AM Eastern on October 20th....